Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland?

European Journal of Epidemiology

Volumn 22, Issue 2, 2007, Pages 83-89

  Kabir, Zubair ^a   Bennett, Kathleen ^a   Critchley, Julia A ^b   Capewell, Simon ^c  

^a ST JAMES S HOSPITAL   (Ireland)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Coronary heart disease; Epidemiological modelling; Ireland; Risk factors

Indexed keywords

CHOLESTEROL;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; MALE; MORTALITY; OBESITY; PHYSICAL ACTIVITY; REDUCTION; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HEALTH BEHAVIOR; HUMANS; IRELAND; MALE; MIDDLE AGED; MODELS, THEORETICAL; MORTALITY; RISK FACTORS; STATISTICS;

EID: 33947413881     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9098-6     Document Type: Article

References (38)

1. Global Cardiovascular Infobase. Accessed at: http://cvdinfobase.ca (31st March, 2006).
2. Bennett K, Kabir Z, Unal B, et al. Explaining the decreasing coronary heart disease death rates in Ireland, 1985-2000. J Epidemiol Community Health 2006; 60: 322-327.
3. Information management unit Department of Health and Children. Public Health Information System (PHIS). [8], Ireland, 2001.
4. Department of Health and Children. Building Healthier Hearts Report of the National Cardiovascular Health Strategy, Dublin, 1999.
5. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br Med J 1994; 309: 23-27.
6. Goldman L, Phillips KA, Coxson P, et al. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Col Cardiol 2001; 38: 1012-1017.
7. Beaglehole R, Magnus P. The search for new risk factors for coronary heart disease: Occupational therapy for epidemiologists? Int J Epidemiol 2002; 31: 1117-1122.
8. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994; 308: 367-372.
9. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81: 380-386.
10. Critchley J, Capewell S. Why model coronary heart disease? Eur Heart J 2002; 23: 110-116.
11. Capewell S, Beaglehole R, Seddon M, McMurray J. Explaining the decline in Coronary Heart Disease Mortality in Auckland, New Zealand between 1982 and 1993. Circulation 2000; 102: 1511-1516.
12. Unal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales, 1981-2000. Circulation 2004; 109: 1101-1107.
13. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 1997; 277: 535-542.
14. Kabir Z, Bennett K, Shelley E, et al. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland. QJM 2006; 99: 523-530.
15. Unal B, Critchley JA, Capewell S. Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality. J Clin Epidemiol 2005; 58: 733-740.
16. Kuulasmaa K, Tunstall PH, Dobson AJ, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project. Lancet 2000; 355: 675-687.
17. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
18. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet 2005; 366: 1640-1649.
19. Kahn EB, Ramsey LT, Brownson, et al. The effectiveness of interventions to increase physical activity. A systematic review. Am J Prev Med 2002; 22: 73-107.
20. Kabir Z, Bennett K, Shelley E, et al. Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland. Eur J Pub Health 2006; June 23 (ahead of print).
21. Centers for Disease Control and Prevention. Declines in Lung Cancer Rates - California, 1988-1997 Morb Mortal Wkly Rep 2000; 49: 1066.
22. De Backer G , Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-1610.
23. Dowse GK, Gareeboo H, Alberti KG, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. Br Med J 1995; 311: 1255-1259.
24. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis. Health Econ. 1994; 3: 95-104.
25. Vartiainen E, Jousilahti P, Alfthan G. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000; 29: 49-56.
26. Smoking-Attributable Mortality, Morbidity, and Economic Costs. Massachusetts, 1998 and similar reports for 1996 and 1997. The Bureau of Health Statistics, Research and Evaluation, Massachusetts Department of Health. November 1999.
27. Manley MW, Glynn TJ, Shopland D. The impact of cigarette excise taxes on smoking among children and adults: summary report of a National Cancer Institute Expert Panel. Bethesda, Maryland: National Cancer Institute, 1993.
28. Kabir Z, Clancy L. Preventive oncology. Lancet 2004; 363: 1737.
29. Allwright S, Paul G, Greiner B, et al. Legislation for smoke-free workplaces and health of bar workers in Ireland: Before and after study. Br Med J 2005; 331: 1117.
30. Office of Tobacco Control, Ireland. Accessed at: http://www.otc.ie. (31st March 2006).
31. National Center for Tobacco-free Kids. Map of state cigarette tax rates-2004. Accessed at: http://tobaccofreekids.org/research/factsheets/pdf/ 0222.pdf. (1st November 2006).
32. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. Br Med J 2006; 332: 629-635.
33. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003; 42: 1093-1099.
34. Glenny AM, O'Meara S, Melville A, Sheldon TA, Wilson C. The treatment and prevention of obesity: A systematic review of the literature. Int J Obes Relat Metab Disord 1997; 21: 715-737.
35. The National Health and Lifestyles Survey. Dublin and Galway: Health Promotion Unit, Centre for Health Promotion Studies & Department of Public Health Medicine and Epidemiology, 2003.
36. McPherson K, Britton A, Causer L. Coronary heart disease: Estimating the impact of changes in risk factors. 1-60. 2002. National Heart Forum 2002. ISBN 0 -11- 702864- 9.
37. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. JAMA 2003; 290: 86-97.
38. Fichtenberg C, Glantz S. Association of the California tobacco control program with declines in cigarette consumption and mortality from heart disease. N Engl J Med 2001; 343: 1772-1777.